QualityStocks Small-Cap and Micro-Cap Blogs: April 2020

Thursday, April 30, 2020

QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Developing Consumer-Managed Data Marketplace

SRAX (NASDAQ: SRAX), a digital marketing and consumer-data-management technology company, enables consumers to own their own data and be compensated for the release of that date. An article discussing the company reads, “SRAX’s focus is its consumer-powered, data-management platform that rewards consumers while enabling businesses to obtain fully informed, consumer opted-in data. Also issues of privacy and data ownership are of increasing concern to consumers. They expect to keep data private as privacy laws on both the state and federal level are putting the value and control of data back in the hands of consumers. Social platforms such as Facebook, Twitter, Snapchat, LinkedIn and others are facing backlash from consumers over privacy concerns. . . .SRAX’s BIGtoken solution enables consumers to own their own data and get remunerated for the release of their data. With BIGtoken’s secure platform, consumers have control over what data is shared, who can buy it and how it’s used (http://ibn.fm/PfdCb). Furthermore, businesses gain consumer data that is passed through numerous layers of verification for premier accuracy.”

To view the full article, visit http://ibn.fm/nYICB

About SRAX

SRAX is a digital marketing and consumer-data-management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and the characteristics of those consumers across marketing channels. Monetizing its data sets, SRAX is growing multiple recurring-revenue streams through its various platforms. Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby offering everyone in the internet ecosystem choice, transparency and compensation. SRAX’s tools deliver a digital competitive advantage for brands in the CPG, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform. For more information, visit the company’s website at www.SRAX.com.

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Advancing CancerQuest2020 Initiative

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, recently reported that its Helomics subsidiary is making headway toward its goal of developing an AI-driven predictive model of ovarian cancer (http://ibn.fm/mENY6). An article discussing the company reads, “This achievement will be a key milestone for the company’s CancerQuest2020 initiative. . . . CancerQuest2020 is focused on building an AI-driven model of ovarian cancer that will predict drug response and outcome leveraging Helomics’ huge knowledge base of tumor profiles. Predictive models embody the knowledge from these profiles to create a ‘computational expert’ or a ‘virtual patient’ that can be queried. Predictive models such as these are of high value to pharmaceutical companies as they can be used to quickly select patients for clinical trials and assess potential new drugs or biomarkers computationally (‘in silico’) before initiating expensive laboratory experiments. In short, Helomics’ predictive models will save time and money in the search for new targeted therapies. . . . Using the power of AI, the model draws on data generated from over 150,000 tumor cases.”

To view the full article, visit http://ibn.fm/x0Uen

About Predictive Oncology Inc.

Predictive Oncology operates through three segments (domestic, international and other) that contain four subsidiaries; Helomics, TumorGenesis, Skyline Medical and Skyline Europe. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomics’ CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based road map for therapy. In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor(TM), patient-derived tumor models coupled with a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary bioinformatics platform to provide a tailored solution to its clients’ specific needs. Predictive Oncology’s TumorGenesis subsidiary is developing a new rapid approach to growing tumors in the laboratory, which essentially “fools” cancer cells into thinking they are still growing inside a patient. Its proprietary Oncology Discovery Technology Platform Kits will assist researchers and clinicians to identify which cancer cells bind to specific biomarkers. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms, which isolate and help categorize an individual patient’s heterogeneous tumor samples to enable the development of patient-specific treatment options. Helomics and TumorGenesis are focused on ovarian cancer. Predictive Oncology’s Skyline Medical division markets its patented and FDA-cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. The company has achieved sales in five of the seven continents through both direct sales and distributor partners. For more information, please visit www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About QualityStocksNewsBreaks

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Trxade Group, Inc.’s (NASDAQ: MEDS) Integral Role in Efforts to Combat COVID-19 Featured in NetworkNewsAudio Podcast

Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, was featured in an exclusive NetworkNewsWire (“NNW”) audio podcast, via NNW’s audio press release solutions suite. The podcast contains NNW editorial coverage titled, “Medical Supply Companies Take on Crucial Role in Combatting Coronavirus” (http://ibn.fm/moaKe). Among other companies providing different critical elements in combating COVID-19, the editorial features Trxade and its role in delivering products and facilitating services to combat the virus’ spread locally. According to the editorial, “Integral to the efforts of over ten thousand pharmacies to procure and deliver essential supplies, Trxade Group Inc. (NASDAQ: MEDS) plays an increasingly important role in that indispensable supply chain. An integrated pharmaceutical services company, Trxade provides the technology backbone for independent pharmacies across the nation, delivering buying power and cost savings. Trxade offers a unique combination of products and services, including a web-based purchasing platform for transactions between independent pharmacists and drug distributors; a network of pharmacies with E-Hub software; a mail-order pharmacy; and warehouse and drug delivery services. This myriad of offerings puts the company in a strong position to support America’s patients and healthcare heroes with the products they desperately need.”

To listen to the podcast, visit http://ibn.fm/OEL2L

About Trxade Group, Inc.

Headquartered in Tampa, Florida, Trxade Group, Inc. (NASQAQ: MEDS) is an integrated drug procurement, delivery and healthcare platform that enables price transparency and increased profit margins to buyers and sellers of pharmaceuticals, makes healthcare services affordable and accessible across all 50 states, and steps in to meet today’s immediate demands. Founded in 2010, Trxade Group is comprised of four synergistic operating platforms; the Trxade B2B trading platform with 12,100 registered pharmacies, a licensed virtual Wholesaler, affordable healthcare via its Bonum Health app or web-based telehealth services, and same day or mail order pharmacy delivery capabilities via its DelivMeds app featuring its extensive nationwide distribution network. For additional information, please visit www.Trxade.com.

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS

About QualityStocksNewsBreaks

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Sugarmade Inc. (SGMD) Announces Expansion of Cannabis Home-Delivery Service to Southern California

SGMD expanding BudCars Cannabis Delivery Service into LA area
Sugarmade forecasts BudCars business to top $30 million in annualized revenues in Sacramento alone
Company sees potential for up to 20 new BudCars hubs across California over next two years

Sugarmade Inc. (OTCQB: SGMD), a product and branding marketing company investing in operations and technologies with disruptive potential and an early pioneer within California’s regulated cannabis industry, announced that its recently acquired BudCars Cannabis Delivery Service is expanding into the Southern California marketplace (http://ibn.fm/o7WiJ). Initially launched in the Sacramento area, the cannabis home-delivery service has seen unprecedented growth in its first months of operation.

“Our Sacramento locations will pass the $10 million mark for annualized sales within the next 60 to 90 days,” Sugarmade CEO Jimmy Chan stated in a news release. “The growth has been so dramatic that we have had to drastically revise our expectations to the upside, which demands expansion, both in terms of staff and fleet in Sacramento, and in terms of regional expansion into Southern California. As a result, we are acquiring two distribution hub locations in the LA area with cannabis licenses included so we can hit the ground running.”

In the expansion announcement, the company reported that BudCars’ primary Sacramento locations have seen tremendous growth, with revenues consistently increasing 10% week over week. While the growth has been attributed to exploding demand for contactless delivery of cannabis products due to the COVID-19 pandemic, company officials expect the upward spike to continue, even after social-distancing restrictions are loosened. SGMD forecasts its BudCars business to top $30 million in annualized revenues this year in Sacramento alone.

In addition, based on data gathered from its current operations as well as trends in the LA region, the Sugarmade team is confident that each of the two new LA BudCars hubs will provide an annual revenue run-rate of $15 to 20 million – as a moderate baseline estimate. Sugarmade officials pointed to its Sacramento locations, which are reporting a consistent 19–20% net profit on sales, noting that the same margins are expected in the Southern California market.

The two LA locations are just the beginning of the CarBuds expansion. Officials see further expansion potential for up to as many as 20 new BudCars hubs across California over the coming two years, funded primarily by cash from operations.

“We are hiring and expanding our fleet as fast as we can right now to keep up with demand,” said Chan. “We can’t expand fast enough. But that’s a great problem to have, and LA represents an ideal new market for BudCars.”

As one of the few cannabis companies pursuing a vertically integrated business model, SGMD is placing its current focus on the expansion of non-storefront cannabis delivery. In addition to BudCars, the Sugarmade brand portfolio includes CarryOutsupplies.com, SugarRush(TM) and Budcars.com. Sugarmade has benefitted from a remarkable growth spurt thus far in 2020 and will seek to maintain its recent trajectory going forward.

For more information, visit the company’s website at www.Sugarmade.com

NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://ibn.fm/SUGAR

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Pressure BioSciences, Inc. (PBIO) Enters LOI to Acquire SkinScience Labs through Cannaworx

Pressure BioScience (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, cosmeceuticals, nutraceuticals, and food & beverage industries, today announced a letter of intent (“LOI”) to acquire SkinScience Labs, Inc., parent company of the award-winning Dr. Denese skin care and anti-aging product lines. Per the update, the rights to acquire SkinScience Labs, which includes Dr. Denese SkinScience, is through Cannaworx, Inc., for which PBI announced plans to acquire on April 28, 2020. “The Dr. Denese SkinScience brand has reached top performing status on QVC for a skin care line, selling over 25 million units and receiving multiple QVC customer choice beauty awards,” PBI President and CEO Richard T. Schumacher said in the news release. “Adrienne’s tremendous brand recognition, regularly repeating customer base, and major existing sales momentum brings immediate accretive impact into the PBI portfolio – and we know that our UST nanoemulsions will create powerful new leverage and opportunities for her expanding product lines. Our team has worked very hard to bring this pivotal transition together for PBI and its shareholders, and we are very excited about the prospects for growth and value appreciation in our combined companies going forward.”

To view the full press release, visit http://ibn.fm/7E2GG

About Pressure BioSciences Inc.

Pressure BioSciences is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life-sciences industry. The company’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure-cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented, enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). PBIO’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of its pressure-based technologies in the following areas: (1) the use of its recently acquired, patented technology from BaroFold Inc. (the “BaroFold” technology) to allow entry into the biopharma contract services sector, and (2) the use of its recently patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and (ii) prepare higher-quality, homogenized, extended shelf-life or room-temperature, stable, low-acid liquid foods that cannot be effectively preserved using existing nonthermal technologies. For more information, visit the company’s website at www.PressureBiosciences.com.

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO

About QualityStocksNewsBreaks

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Sigma Labs Inc. (NASDAQ: SGLB) Positioned to Meet Expected Post-COVID Demand for 3D Metal Printed Parts with In-Process QA Technology

Sigma Labs provides critical in-process monitoring technology to unlock scalability needed to meet parts demand
3D printed medical devices of all source materials market forecast to reach $26 billion over two years
As industry reacts to current crisis, demand for 3D metal printed parts expected to increase

From specialized surgical tools designed to meet a surgeon’s unique needs to customized cutting guides for knee replacements, the healthcare industry is poised to be transformed by additive manufacturing (AM), also known as 3D printing (http://ibn.fm/q3ROJ). However, scalability has been limited by the technology’s lack of in-process quality control monitoring. Sigma Labs Inc. (NASDAQ: SGLB), a company specializing in real-time quality assurance of 3D metal printing, presents a solution to alleviate the onerous burden of quality assurance in mass production – at a time when the 3D printed medical devices market is expected to reach $26 billion over the next two years.

While 3D printing technology (also known as additive manufacturing) has long been used to create product prototypes, the lack of product uniformity and onerous quality assurance costs had made engaging in mass production a pipe dream. Sigma Labs, one of the leading providers of third party in-process quality assurance software to the commercial 3D metal printing industry, has allowed companies to monitor the quality of each product part in the production process, layer by layer and in real time – leading to a dramatic decrease in error rates and higher manufacturing yields.

According to industry think-tank SME, the 3D printed medical devices sector – which already accounts for 17 percent of the total additive manufacturing (AM) market – will grow to roughly $26 billion over the next 24 months. A key segment spearheading growth in the sector has been the design and fabrication of replacement joints and artificial limbs. Over 30 million people worldwide are in need of artificial limbs and mobility devices, yet less than 20 percent have access to them, largely due to the extremely time-consuming and expensive process of producing customized prosthetics. 3D printing has sought to address this issue by enabling an ever-increasing number of patients, particularly from developing nations, to gain access to bespoke prosthetic limbs. Healthcare NGO e-NABLE has been one of the pioneers in the field, publishing free designs for prosthetic hands, which are available for anyone to print and can cost as little as $35 (http://ibn.fm/YddEE).

However, the industry’s prodigious growth rate has not been limited to well-documented manufacturing breakthroughs such as the design of hearing aids, dental implants and prostheses. In northern Italy’s Lombardy region, a shortage of ventilators in the midst of the viral outbreak was compounded by a lack of replacement valves for faulty machines. With medical suppliers unable to provide spare parts at short notice, 3D printing experts and local business owners were able to collaborate and come to the rescue by rapidly fabricating the replacement parts within a matter of hours (http://ibn.fm/E8xDs). Similarly, in the United States, Massachusetts-based Formlabs, a manufacturer of 3D printers, was able to swiftly reformat over 250 of their printers to produce 100 thousand nasal swabs for COVID-19 testing a day (http://ibn.fm/67WPy). With the scope of 3D printed medical devices widening on a daily basis, product safety has increasingly become a factor alongside other variables such as production cost, product longevity and functionality. As such, the need for a robust, efficient and easily implementable quality assurance process has become paramount.

To meet this requirement, Sigma Labs PrintRite3D(R) caters to the highly technical and precise nature of the Additive Manufacturing 3D metal branded equipment being created. In early April, the company launched the newest iteration of its revolutionary PrintRite3D(R) software, providing manufacturers with the ability to remotely monitor their 3D printing process in real-time while offering actionable information and AI-driven metrics on a production management user-interface platform. Moreover, Sigma’s technology can be used on 3D printers from multiple manufacturers to provide a consistent standard of quality assurance, thereby allowing for the technology to be deployed throughout a manufacturer’s supply chain (http://ibn.fm/ejfV5).

Following the launch and during a recent interview with Proactive Investors, Sigma Labs Chairman Mark Ruport went on to reaffirm that the company was now eyeing a “tremendous opportunity” to become the de facto standard for third party in-process quality assurance of metal parts production (http://ibn.fm/XnYS3).

The application of 3D printing within medical hardware and healthcare has allowed the industry to access critical components as and when they are needed – all at reduced cost, time, and wastage relative to traditional manufacturing methods. However, 3D printing will only truly surpass traditional techniques when the additive manufacturing industry moves from ‘post-process’ quality control to ‘in-process’ quality assurance. As one of the leaders in its field, Sigma Labs and its technological solutions are well positioned to capitalize on the industry’s explosive growth going forward.

For more information about Sigma Labs, please visit www.SigmaLabsInc.com

NOTE TO INVESTORS: The latest news and updates relating to SGLB are available in the company’s newsroom at http://ibn.fm/SGLB

About QualityStocks

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Cannabis Global, Inc. (MCTC) Announces Cannabinoid Sciences Research Breakthrough Unveiled by “Project Varin”

Cannabis Global (OTC: MCTC), a cannabinoid and hemp extract science forward company developing infusion and delivery technologies, today announced a research breakthrough in the field of cannabinoid sciences resulting from the company’s “Project Varin,” which began earlier this year. According to the update, the research program has yielded a new tetrahydrocannabivarin (“THC-V”) delivery system providing for sustained release of the cannabinoid over a predetermined period of time, as well as two other delivery systems for immediate release. “While these developments add to our growing list of intellectual property, these are much more than technologies that will sit on a shelf,” Cannabis Global CEO Arman Tabatabaei said in the news release. “We have already integrated both the sustained and immediate release versions into beverage products that we expect to be available to consumers next month. We believe the field of minor and exotic cannabinoids will grow substantially this year with several product introductions. We are extremely excited at the prospect of being a first mover in this emerging market segment.”

To view the full press release, visit http://ibn.fm/SHoB9

About Cannabis Global, Inc.

Cannabis Global, Inc. (MCTC) is a Nevada registered, fully reporting and audited publicly-traded company. With the hemp and cannabis industries moving very quickly and with a growing number of market entrants, Cannabis Global plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The Company plans to actively pursue R&D programs and productization for exotic cannabinoid isolation, bioenhancement of cannabinoids and polymeric solid nanoparticles and nanofibers for addition into consumer products and for dermal application. The Company was reorganized during June of 2019 and announced its intent to enter the fast-growing cannabis sector. The company is headed and managed by a group of highly experienced cannabis industry pioneers and entrepreneurs. For more information, visit the company’s website at www.CannabisGlobalinc.com.

NOTE TO INVESTORS: The latest news and updates relating to MCTC are available in the company’s newsroom at http://ibn.fm/MCTC

About QualityStocksNewsBreaks

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Sigma Labs, Inc. (NASDAQ: SGLB) to Host Q1 Results Conference Call on May 14, 2020

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the additive manufacturing industry, today announced that it will host a conference call at 4:30 PM ET on Thursday, May 14, 2020, to discuss its results for the first quarter ended March 31, 2020. A press release detailing the results will be issued prior to the call that will be hosted by Sigma Labs Executive Chairman Mark Ruport, CEO John Rice and CFO Frank Orzechowski. Interested parties may access the call by dialing 1-877-407-9039 (Toll-free) or 1-201-689-8470 (International) and entering Conference ID: 13702566. The conference call will be broadcast live and available for replay at http://ibn.fm/IXqBf and via the investor relations section of the company’s website.

To view the full press release, visit http://ibn.fm/viEcf

About Sigma Labs

Sigma Labs, Inc. is a leading provider of quality assurance software to the commercial 3D metal printing industry under the PrintRite3D(R) brand. Sigma specializes in the development and commercialization of real-time monitoring solutions known as PrintRite3D(R) for 3D metal advanced manufacturing technologies. PrintRite3D detects and classifies defects and anomalies real-time during the manufacturing process and informs the production manager of quality issues. Sigma Labs’ software product is a major catalyst for the acceleration and adoption of 3D metal printing. For more information, visit the company’s website at www.SigmaLabsInc.com.

NOTE TO INVESTORS: The latest news and updates relating to SGLB are available in the company’s newsroom at http://ibn.fm/SGLB

About QualityStocksNewsBreaks

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Featured in Dougherty & Company LLC Research Report

Trxade Group (NASDAQ: MEDS) was featured in a recent equity research report published by Dougherty & Company LLC. The report reads, “We are initiating coverage of Trxade with a Buy rating and Price Target of $12. MEDS’ primary offering is a web-based platform connecting large suppliers of branded and generic drugs with retail and independent pharmacies. The platform offers full price transparency, comparing the prices and availability across a variety of suppliers. Its latest offering is a direct-to-consumer application equipped with telemedicine visits which includes home delivery of medications. MEDS nearly doubled revenue in 2019 and we model the company increasing sales at close to a 40% clip in 2020, while profitable for several quarters. We view the stock as a compelling, under-the-radar idea for small-cap growth investors seeking exposure to digital health and telemedicine. Our $12 Price Target is based on a 6x multiple on our 2021 forecast, a slightly lower multiple than comps which we justify with a small cap discount, but considering also MEDS’ superior growth rate.”

To request access to the full report, visit http://ibn.fm/LQ1QX

About Trxade Group, Inc.

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS

About QualityStocksNewsBreaks

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

InsuraGuest Technologies Inc. (TSX.V: ISGI) Licensed to Sell Insurance in 48 States, Expects Approval for Remaining Two Within a Month

The specialized insurance provider is expanding into multiple specialized sectors, focuses on higher service speed and personalization
Hospitality Liability Policy covers theft and damage of personal property, accidental medical expenses, and accidental death and dismemberment
Insurtech sector growing at a fast pace, attracting billions in investment

InsuraGuest Insurance Agency LLC, wholly owned by insurtech software company InsuraGuest Technologies Inc. (TSX.V: ISGI), is now licensed to sell all lines of insurance in 48 out of the 50 U.S. states and Washington, D.C. “As the world navigates and accommodates to new changes due to COVID-19, we continue to forge forward and build InsuraGuest to produce more product offerings so we can better serve our customers and build shareholder value,” InsuraGuest Technologies CEO and Chairman Douglas Anderson stated in a company press release (http://ibn.fm/8ZwFu).

The Agency is registered and licensed to sell accident and health, casualty, life and property insurance in Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming and the District of Columbia.

The Agency has applied and expects to be approved to sell insurance in the remaining two states of Massachusetts and New York within the next 30 days.

Insurance is one of the oldest and most traditional industries. Over the past few years, insurtech software company InsuraGuest Technologies have begun to encroach on major players’ territory by providing an insurtech software platform which can deliver digital insurance to multiple sectors. Insurtech in particular has seen a sharp increase in funding, with approximately $16.5 billion invested in the sector over the past 10 years. The pace of investment is on the rise (http://ibn.fm/Ck9uq), with $2.2 billion raised in the first half of 2019 alone (http://ibn.fm/VNo47).

InsuraGuest Technologies’ insurtech software currently targets hotels and vacation rentals, with the long-term goal to expand offerings to a wider audience and into revenue streams. The company aims to move into providing its software, that alleviates the process of insuring mainstream sectors, with a focus on providing higher service speed, ease of purchasing insurance, and personalization. InsuraGuest is working to expand its product offering and the reach of its platform via brokers and agents who can sign up instantly through a fully automatized agency/broker software program. These agents and brokers can then take InsuraGuest’s current Hospitality Liability product to their own customers, helping speed up the platform and products’ expansion.

The company’s proprietary insurtech software platform is already operational in the hospitality industry, where it provides specialized gap insurance, which can address accidents or theft incurred by a guest during their stay at hotels and vacation rental properties. Traditional travelers’ insurance doesn’t cover a number of things that can happen inside hotels or other travel properties, putting both the traveler and the hotel or property owner at risk. InsuraGuest’s proprietary insurtech platform delivers its specialized Hospitality Liability coverages to its hotel and vacation rental members, which becomes the first line of defense for the properties if an accident or theft is incurred by a guest or their occupants during their stay. The Hospitality Liability coverages address a wide range of issues, from theft and damage of personal property to accidental medical expenses, death and dismemberment.

For more information, visit the company’s website at www.InsuraGuest.com

NOTE TO INVESTORS: The latest news and updates relating to ISGI are available in the company’s newsroom at http://ibn.fm/ISGI

About QualityStocks

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Announces Complete Vertical Integration of Ketamine Treatments/Therapies, Closing of AltMed Acquisition

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) continues to strengthen its vertically integrated psychedelic medicine ecosystem via the acceleration of its ketamine topicals prescription fulfillment capabilities. The company today announced the addition of central fill and compounding infrastructure for its proprietary ketamine formulations via a location at one of Canada’s leading retail pharmacy chains (the “Pharmacy”), as well as the dispensing of its products throughout the Pharmacy’s network. “With this arrangement, Champignon boasts complete vertical integration with respect to our rapid onset ketamine treatments and therapies,” Champignon CEO Gareth Birdsall stated in the news release. “From novel formulations to product development at a purpose-built GMP and DIN licensed pharmaceutical facility, and now automated prescription fulfillment and on-site compounding infrastructure, we have managed to capture the entire product lifecycle.”

In addition, Champignon announced the closing of its acquisition of AltMed Capital Corp., subject to the submission of the necessary filings to the BC Corporate Registry and including any other necessary regulatory approvals. AltMed is a Canadian ketamine clinic operator, psychedelic medicine IP aggregator and novel drug discoverer with a suite of assets that will accelerate Champignon’s multipronged business strategy. This will enable the company to reach the consumer directly through rapid-onset medical treatments, with an anticipated rollout of already identified new clinical entities (“NCEs”) to be opened across the United States and Canada.

To view the full press release, visit http://ibn.fm/zTUCj

About Champignon Brands Inc.

Champignon Brands Inc. is a research-driven company specializing in the formulation of a suite of medicinal mushrooms health products, as well as novel ketamine, anaesthetics and adaptogenic delivery platforms for the nutritional, wellness and alternative medicine industries. Via its vertically integrated alternative medicine product range, Champignon is pursuing the development and commercialization of rapid onset treatments capable of improving health outcomes, such as depression and post-traumatic stress disorder (“PTSD”), as well as substance and alcohol use disorders. Under a collaborative research agreement with the University of Miami’s Miller School of Medicine, the Company is conducting pre-clinical studies and eventual human clinical trials, with the objective of demonstrating safety and efficacy of the combination of psilocybin and cannabidiol in treating mTBI with PTSD or stand-alone PTSD. Champignon continues to be inspired by sustainability, as its medicinal mushroom-infused SKUs are organic, non-GMO and vegan certified. For more information, visit the company’s website at www.Champignonbrands.com.

NOTE TO INVESTORS: The latest news and updates relating to SHRM are available in the company’s newsroom at http://ibn.fm/SHRM

About QualityStocksNewsBreaks

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – National Storm Recovery Inc. (NSRI) Achieves ‘Current Information’ Status with OTC Markets Group

National Storm Recovery (OTC: NSRI), a provider of tree services, debris hauling, removal and bio-mass recycling, manufacturing, packaging and sales of next-generation mulch products, today announced that it has obtained “Current Information” status with OTC Markets Group. Based on the information they provide to investors, OTC Markets organizes pink companies into current, limited or no information categories. Achieving Pink Current Information status emphasizes NSRI’s commitment to meeting reporting deadlines and providing transparency to potential and current shareholders. “We are pleased to announce NSRI’s Current Information status as a measurement of the company’s broader growth strategy. This determination allows new investors to own a stake in NSRI while providing a platform from which we can offer full transparency on our progress,” NSRI CEO and Director Anthony “Tony” Raynor stated in the news release.

To view a comprehensive presentation of the company’s operations, expansion plans and production facilities, visit http://ibn.fm/ptRvR

To view the full press release, visit http://ibn.fm/lClPq

About National Storm Recovery, Inc.

National Storm Recovery, through its subsidiaries, provides tree services, debris hauling and removal, biomass recycling, mulch manufacturing, packaging and sales. The company was established with the objective of providing a solution for the treatment and handling of tree debris that has historically been disposed of in landfills, creating an environmental burden and pressure on disposal sites around the nation. The company and its Sustainable Green Team’s solutions are founded in sustainability, based on vertically integrated operations that begin with collecting of tree debris through its tree services division and collection sites, then through processing, recycling and using that tree debris as feedstock that is manufactured into a variety of organic, attractive, next-generation mulch products that are packaged and sold to landscapers, installers and garden centers. The company plans to expand its operations through a combination of organic-growth and strategic acquisitions that are both accretive to earnings and positioned for rapid growth from the resulting synergistic opportunities identified. NSRI serves governmental, residential and commercial customers. For more information, visit the company’s website at www.NationalArborCare.com.

NOTE TO INVESTORS: The latest news and updates relating to NSRI are available in the company’s newsroom at http://ibn.fm/NSRI

About QualityStocksNewsBreaks

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Grey Cloak Tech Inc. (GRCK) Expands Product Offerings through Citrus Bergamot SuperFruit(TM) IMMUNE Launch

Grey Cloak Tech (OTC: GRCK) on Wednesday announced the launch of a new product developed by the company’s BergaMet NA subsidiary, Citrus Bergamot SuperFruit(TM) IMMUNE. BergaMet NA’s proprietary formulation naturally supports healthy immune systems in humans, and is specifically designed to help cardiovascular health, blood sugar maintenance, address internal inflammation, and other metabolic conditions. BergaMet’s IMMUNE, HERHEART, SPORTSHEART and other products are available on the BergaMet website (www.BergaMetNA.com) as well as on Amazon, various other online retailers and in doctors’ offices throughout the United States. “I am excited to add Citrus Bergamot SuperFruit(TM) IMMUNE to our great lineup of products. The expansion of our product offerings underscores our commitment to provide people an all-natural solution formulated to improve metabolic syndrome. As everyone knows a healthy diet and exercise are important for overall well-being, however, not everyone can achieve their desired results. Consumers can start taking control of their own health with two daily Citrus Bergamot SuperFruit(TM) tablets for less than a dollar a day,” Grey Cloak Tech CEO Kevin “Duke” Pitts stated in the news release.

To view the full press release, visit http://ibn.fm/NI6Sd

About Grey Cloak Tech Inc.

Grey Cloak Tech Inc. (OTC: GLCK), through its two subsidiaries, BergaMet NA and Ultimate Brain Nutrients, is engaged in proprietary research and development of natural plant-based formulations, as well as sales and distribution of cardiovascular and neuro products. For more information, visit the company’s websites at http://greycloaktech.com, http://bergametna.com, and http://ubnutrients.com.

NOTE TO INVESTORS: The latest news and updates relating to GRCK are available in the company’s newsroom at http://ibn.fm/GRCK

About QualityStocksNewsBreaks

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Wednesday, April 29, 2020

Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Outlines Three Objectives for Coming Year, Reaffirms Strong Foundation as Cannabis Industry Leader

PLUS well-prepared to respond to current coronavirus crisis, says CEO
Strengthening PLUS presence in the California market remains critical to becoming global cannabis brand
When objectives are met, few companies will be better positioned to build global portfolio of cannabis brands

Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) has identified three critical objectives to focus on in the coming year, according to a letter from PLUS co-founder and CEO Jake Heimark (http://ibn.fm/g9qEv). The letter outlines those objectives and also discusses COVID-19 and the impact it is expected to have on the company.

After observing that the company is “well-prepared to respond to the current coronavirus crisis,” Heimark noted that the company “continues to have a strong foundation as a leader in the California cannabis market.”

“We have set three critical objectives as a company over the next four quarters,” he stated. “1) to ensure the safety and health of our employees and customers, 2) to continue to establish ourselves as a clear, long-term leader in the California edibles space and 3) to become a cash-flow positive business.”

Heimark then went on to explain that PLUS is “capitalized with enough cash on hand to continue executing through the entirety of 2020 without any additional fundraising.” Heimark noted that “Plus Products was the largest brand in the largest category of the California edibles market in 2019, and had the two best-selling cannabis products, across all categories, in the state over that same period.”

In his letter, Heimark explained that, in 2019, the state’s emerging adult-use cannabis market was 38% of the global adult-use cannabis market, and it is expected to stay at least 27% of that market through 2024. “Edibles remain the most attractive space to build a brand, with price premiums remaining constant, while other categories continue to see significant price degradation,” Heimark said. With that in mind, it makes sense that maintaining – and even building – the PLUS presence in the California market remains critical to becoming a global cannabis brand, he concluded.

Calling 2019 a difficult year for the entire cannabis industry, Heimark observed that “macro events – ranging from the vaping crisis to slow growth in emerging markets – contributed to underwhelming results and immense pressure from the market on operators across the board, a pressure that has continued to impact the industry into the new year.” Heimark acknowledged that PLUS hadn’t escaped the challenges.

“We have faced a home market in California that continues to battle growing pains as it works to compete with a highly active illicit market, streamline a disorderly regulatory environment, and support undercapitalized operators across an adolescent supply chain,” he said. “As a result, growth has been less robust than anticipated, and we were not spared from the broader market downturn.”

With that in mind, the Plus Products leadership team made adjustments to the business to ensure that the company is in the ideal position to survive – and succeed – in 2020 and 2021. Those adjustments included executive salary reductions, executive reorganization, general personnel reductions, the conclusion of the John Legend engagement and an employee equity incentivization restructure. “The decisions made were driven by a strategic commitment to prioritize growing our footprint in markets in which we are already operational over entry into new markets, with a particular focus on our home state of California,” Heimark explained.

“PLUS has built one of the most successful brands in the world’s largest cannabis market,” he concluded. “Moving ahead we intend to build a strong portfolio of edibles brands, leveraging our core capabilities in markets where we have established distribution channels and a dedicated customer base… We believe that we have a clear path to achieving our three critical objectives set forth above. If we do, there will be few, if any, companies better positioned to build a global portfolio of cannabis brands. And while these are uncertain times, we know that we will emerge from this moment in time together.”

Headquartered in San Mateo, California, PLUS is a cannabis and hemp food company focused on using nature to bring balance to consumers’ lives. PLUS’s mission is to make cannabis safe and approachable, beginning with high-quality products that deliver consistent consumer experiences.

For more information, visit the company’s website at www.PlusProducts.com

NOTE TO INVESTORS: The latest news and updates relating to PLPRF are available in the company’s newsroom at http://ibn.fm/PLPRF

About QualityStocks

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Champignon Brands Inc.’s (CSE: SHRM) (OTC: SHRMF) (FWB: 496) New Committee Member Strengthens Compentencies

SHRM appoints former Red Bull Canada president to Special Advisory Committee
New member’s background in heavily regulated industries coupled with experience in CPG space provides great complement
Effective immediately, Champignon common shares being traded on OTCQB Venture Market

Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496), a Canada-based company dedicated to applying novel and natural treatment protocols with an emphasis on psychedelic medicine, announced the appointment of Jim Bailey as a new member of its Special Advisory Committee. The appointment of Bailey, a former president of Red Bull Canada, is designed to strengthen SHRM’s pharmaceutical, nutraceutical and CPG marketing/distribution competencies (http://ibn.fm/UjO9v).

“I am very excited to be part of a company that is leading the way in finding alternative solutions to traditional pharmaceuticals with science-based research and functional products,” Bailey noted in a news release. “My background in heavily regulated industries coupled with my experience in the CPG space provides a great complement to an already talented and experienced advisory board.”

In his position at Red Bull Canada, Bailey played a key role in introducing the Red Bull brand in Canada and growing the business to $150 million in annual revenue with more than 300 employees. In addition to his experience at Red Bull, Bailey served as the global chief marketing office for Merrell Outdoors, overseeing both product and consumer marketing; during his tenure, Merrell Outdoors reported annual revenues of up to $600 million.

In his new position on Champignon’s Special Advisory Committee, Bailey will “champion the marketing, distribution and commercialization of the company’s Novoformulations-branded novel delivery systems for the pharmaceutical, nutraceutical and psychedelic medicine industries,” the company announced.

A wholly owned subsidiary of Champignon, Novoformulations is focused on working with ketamine, anaesthetics and adaptogenics, along with other pharmaceuticals and natural molecules at a purpose-built good manufacturing practice (GMP) and pharmaceutical (DIN) licensed facility located in Quebec. As part of these efforts, Novoformulations is formulating, developing and working to commercialize bioavailable transdermal, intranasal and sublingual delivery platforms.

In addition, Champignon announced that, effective immediately, its common shares are being traded on the OTCQB Venture Market, a U.S. trading platform operated by the OTC Markets Group; the shares will be traded under the ticker ‘SHRMF’ (http://ibn.fm/8mF7O). Champignon’s common shares will continue to trade on the Canadian Securities Exchange under the ticker symbol ‘SHRM’, as well as on the quotation board of the Frankfurt Stock Exchange under the ticker symbol ‘496’.

The OTCQB is the foremost exchange for entrepreneurial and development-stage U.S. and international companies focused on providing superior experience for U.S. investors. To trade on the market, companies must be current in their financial reportings, pass a minimum-bid price test, and undergo an annual company verification and management certification process. Companies that are approved to trade on the OTCQB exchange have met quality standards that provide a strong baseline of transparency and are committed to improving the information and trading experience for investors.

Champignon seeks opportunities to promote the health and wellness benefits of functional mushrooms, which are used in a wide variety of health-care and pharmaceutical products. The company’s flagship e-commerce store, VitalitySuperTeas.com, takes advantage of the burgeoning craft mushroom industry with a selection of mushroom-infused teas and accessories; SHRM is also expanding its preclinical trial pipeline and branching out into alternative medicine and pharmaceuticals.

For more information, visit the company’s website at www.ChampignonBrands.com

NOTE TO INVESTORS: The latest news and updates relating to SHRM are available in the company’s newsroom at http://ibn.fm/SHRM

About QualityStocks

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA) Rebrands as DRIVRZ, Launching Vehicles to a Network of Industry Buyers

DRIVRZ will become PowerBand’s consumer-facing brand in the months and years ahead
The platform is designed to simplify online vehicle transactions allowing users to place orders for cars and trucks from their smartphones, from any location
Company actively participating in the $10-billion cross-border used vehicle export market with receipt of its Exporter License
Over 10 million vehicles are bought and sold through auctions every year

PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA) has announced that it is trademarking the brand DRIVRZ as its top-level logo and wordmark for ongoing consumer interactions and future leasing and finance operations. The company applied to register the DRIVRZ wordmark and DRIVRZ logo in the U.S. and Canada. Trademark protection for DRIVRZ is underway for these countries and world markets. The mark family includes DRIVRZ FINANCIAL and DRIVRZ SOLUTIONS marks.

The company – enabling the buying, selling, leasing, financing and auctioning of cars on mobile devices, from any location – will continue to use PowerBand as its corporate name and retain its current ticker symbols on public markets for investors and regulators.

“As we advance our cloud-based vehicle transaction platform into Canada and the United States, as well as automotive markets around the world, we believe it is essential to have a brand that is clear, unified, easily recognizable and consumer-friendly,” PowerBand Solutions CEO Kelly Jennings stated in a news release (http://ibn.fm/yWgN3). “DRIVRZ will become PowerBand’s consumer-facing brand in the months and years ahead. DRIVRZ is for drivers, taking the unnecessary middlemen out of the automotive retail sector, to make buying, selling, trading and leasing a car or truck as easy as ordering a product from Amazon or ordering an Uber on your smart phone. It is the future of automotive retail.”

In related news, PowerBand and D2D Auto Auctions LLC successfully launched and conducted ‘virtual’ auctions on April 7th and April 16th in the United States, testifying to the speed and efficiency of D2D’s unique transaction platform. This platform provides a much-needed alternative to physical auctions and their associated costs and allows dealers to create an instant, online auction that launches a used vehicle to a vast network of the industry’s top used vehicle buyers. The cost of delivering a vehicle to a physical auction is eliminated (http://ibn.fm/S7d9A).

D2D is co-owned by PowerBand and Arkansas-based financier Bryan Hunt in a 50-50 partnership. More than 1,300 dealers were registered on the D2D platform when it was launched at the end of 2019. This number is increasing rapidly as social distancing takes effect and D2D’s sales team targets additional dealerships and commercial customers, including leasing, rental and fleet companies. The established DriveAway app, piloted by D2D, will continue to operate under its brand in the United States for the buying, selling and trading of cars.

PowerBand also acquired FinTech industry leader MUSA, to carry out transactions in the United States. MUSA will continue to operate under its name in the United States. Its technology takes applications, calculates leases, auto-decisions applications, provides approvals back to dealer partners and prefills lease contracts accurately. MUSA has been used with success by Tesla, which resulted in lease approval in a matter of seconds using the platform.

These developments have helped PowerBand gain a firm foothold in the massive U.S. automotive transaction marketplace. The company also owns an Exporter License, allowing it to actively participate in the $10-billion cross-border used vehicle market. Its leading-edge used-vehicle online remarketing auction platform also incorporates inventory management, the latest auction technologies in the industry, and appraisal processes.

The overall automotive dealership and commercial fleet vehicle auction industry is a $100-billion sector with more than 40 million used vehicles transacted in the U.S. each year. Over 10 million of these vehicles are bought and sold through auctions.

For more information, visit the company’s website at www.PowerBandSolutions.com

NOTE TO INVESTORS: The latest news and updates relating to PWWBF are available in the company’s newsroom at http://ibn.fm/PWWBF

About QualityStocks

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – iClick Interactive Asia Group Limited (NASDAQ: ICLK) Named in CIO Advisor APAC’s Top 10 Ad Management Companies 2020

iClick Interactive Asia Group (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China, today announced that it has been selected as one of the “Top 10 Ad Management Companies 2020” by CIO Advisor APAC. Last year, the company was listed by the publication as Top 10 APAC Digital Marketing Solution Providers-2019. In addition, Sammy Hsieh, iClick Co-founder and Chairman of the Board of Directors, was featured in the April 2020 edition of CIO Advisor’s Ad Management magazine highlighting the company’s services and achievements in the advertising industry. “We are delighted to receive these prestigious accolades which recognize our strong capabilities in both digital marketing and ad management. One of iClick’s fundamental goals is to use advanced marketing technologies to help international brands reach the right audiences in China and optimize their business and marketing efforts. Through our Integrated Enterprise and Marketing Cloud Platform combined with our close understanding of market trends, we help customers turn online and offline data into actionable and monetizable insights,” iClick Co-founder and Chairman of the Board of Directors Sammy Hsieh stated in the news release.

To view the full press release, visit http://ibn.fm/o6ET1

About iClick Interactive Asia Group

iClick Interactive Asia Group Limited is an independent, online marketing and enterprise-data-solutions provider that connects worldwide marketers with audiences in China. Built on cutting-edge technologies, the company’s proprietary platform possesses omni-channel marketing capabilities and fulfills various marketing objectives in a data-driven and automated manner, helping both international and domestic marketers reach their target audiences in China. Headquartered in Hong Kong, iClick was established in 2009 and currently operates in 10 locations worldwide, including Asia and Europe. For more information, visit the company’s website at www.i-Click.com.

NOTE TO INVESTORS: The latest news and updates relating to ICLK are available in the company’s newsroom at http://ibn.fm/ICLK

About QualityStocksNewsBreaks

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Cannabis Strategic Ventures, Inc. (NUGS) Eyes Record-Breaking April Sales in Strong Structural Growth Boom

Cannabis Strategic Ventures (OTCQB: NUGS), an emerging leader in the U.S. cannabis marketplace, today announced that it has seen record total monthly cannabis sales and record sequential monthly cannabis sales growth so far in the month of April. According to the update, the company’s total gross cannabis sales for April are running at an annualized pace of more than $6 million, which is an increase of more than 400% over average monthly sales seen in calendar Q1. “This data should help to better contextualize our prior announcement detailing our expansion in total cannabis production capacity,” Cannabis Strategic Ventures CEO Simon Yu said in the news release. “Demand is through the roof. We don’t see this as a consequence of the stay-at-home policy. This is about improving market positioning in a strong structural growth boom. We are establishing a wider and wider footprint in terms of distribution partners, and the overall market is continuing to experience powerful growth in demand at the end market level.”

To view the full press release, visit http://ibn.fm/pfXFt

About Cannabis Strategic Ventures

Cannabis Strategic Ventures, Inc. (OTC: NUGS) is one of the largest publicly traded marijuana cultivators in the United States. The company is Los Angeles-based that incubates, develops and partners with category leaders within the cannabis and ancillary sectors. The firm’s NUGS brand experience provides operational and financial strategic partnerships and a range of essential services to emerging and existing cannabis consumer brands. For more information, visit www.CannabisStrategic.com.

NOTE TO INVESTORS: The latest news and updates relating to NUGS are available in the company’s newsroom at http://ibn.fm/NUGS

About QualityStocksNewsBreaks

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocks Small-Cap and Micro-Cap Blogs

Thursday, April 30, 2020

QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Developing Consumer-Managed Data Marketplace

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Advancing CancerQuest2020 Initiative

QualityStocksNewsBreaks – Trxade Group, Inc.’s (NASDAQ: MEDS) Integral Role in Efforts to Combat COVID-19 Featured in NetworkNewsAudio Podcast

Sugarmade Inc. (SGMD) Announces Expansion of Cannabis Home-Delivery Service to Southern California

QualityStocksNewsBreaks – Pressure BioSciences, Inc. (PBIO) Enters LOI to Acquire SkinScience Labs through Cannaworx

Sigma Labs Inc. (NASDAQ: SGLB) Positioned to Meet Expected Post-COVID Demand for 3D Metal Printed Parts with In-Process QA Technology

QualityStocksNewsBreaks – Cannabis Global, Inc. (MCTC) Announces Cannabinoid Sciences Research Breakthrough Unveiled by “Project Varin”

QualityStocksNewsBreaks – Sigma Labs, Inc. (NASDAQ: SGLB) to Host Q1 Results Conference Call on May 14, 2020

QualityStocksNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Featured in Dougherty & Company LLC Research Report

InsuraGuest Technologies Inc. (TSX.V: ISGI) Licensed to Sell Insurance in 48 States, Expects Approval for Remaining Two Within a Month

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Announces Complete Vertical Integration of Ketamine Treatments/Therapies, Closing of AltMed Acquisition

QualityStocksNewsBreaks – National Storm Recovery Inc. (NSRI) Achieves ‘Current Information’ Status with OTC Markets Group

QualityStocksNewsBreaks – Grey Cloak Tech Inc. (GRCK) Expands Product Offerings through Citrus Bergamot SuperFruit(TM) IMMUNE Launch

Wednesday, April 29, 2020

Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Outlines Three Objectives for Coming Year, Reaffirms Strong Foundation as Cannabis Industry Leader

Champignon Brands Inc.’s (CSE: SHRM) (OTC: SHRMF) (FWB: 496) New Committee Member Strengthens Compentencies

PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA) Rebrands as DRIVRZ, Launching Vehicles to a Network of Industry Buyers

QualityStocksNewsBreaks – iClick Interactive Asia Group Limited (NASDAQ: ICLK) Named in CIO Advisor APAC’s Top 10 Ad Management Companies 2020

QualityStocksNewsBreaks – Cannabis Strategic Ventures, Inc. (NUGS) Eyes Record-Breaking April Sales in Strong Structural Growth Boom

QualityStocks Links

Blog Archive

About Me